Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN76424181
ISRCTN76424181
Completed
未知

A multi-centre, randomised, double-blind trial studying the effect of misoprostol on the outcome of intra-uterine insemination

niversity Hospital Ghent (Belgium)0 sites217 target enrollmentMay 30, 2007
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
niversity Hospital Ghent (Belgium)
Enrollment
217
Status
Completed
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

2008 Results article in https://doi.org/10.1159/000133951 (added 19/10/2021)

Registry
who.int
Start Date
May 30, 2007
End Date
June 30, 2005
Last Updated
4 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
niversity Hospital Ghent (Belgium)

Eligibility Criteria

Inclusion Criteria

  • •1\. All women presenting for Intra\-Uterine Insemination (IUI)
  • •2\. Between the age of 20 and 36 years
  • •3\. Bilateral tubal patency was proven
  • •4\. Total motile fraction of the semen sample was more than 1 million after preparation
  • •5\. Informed consent

Exclusion Criteria

  • •1\. History of previously failed intra\-uterine insemination
  • •2\. Severe comorbidity (endometriosis, fibroma)
  • •3\. Previous allergic reactions to misoprostol

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
A multi-centre double blind randomised controlled trial of aspirin and/or folate supplementation for the prevention of recurrent colorectal adenomasRecurrent colorectal adenomasCancerMalignant neoplasm of rectosigmoid junction
ISRCTN22669537Cancer Research UK (CRUK) (UK)1,000
Completed
Not Applicable
Rifaximin to reduce infection in decompensated cirrhosisDecompensated cirrhosisDigestive System
ISRCTN10994757Imperial College London78
Completed
Phase 2
Study to verify the effectiveness and safety of the modified isothymol or carvacrol compound against SARS-CoV-2 in COVID-19 patientsCOVID-19 (SARS-CoV-2 infection)Infections and Infestations
ISRCTN15363958Instituto Venezolano de Investigaciones Científicas600
Completed
Phase 3
Effects of ethyl lauroyl arginine nasal spray on COVID-19COVID-19 (SARS-CoV-2 infection)Infections and Infestations
ISRCTN17834262Salvacion LLC30
Completed
Phase 2
Cediranib maleate with or without gefitinib in treating patients with recurrent or progressive glioblastoma
ISRCTN00549973niversity College London (UK)38